The SPON1 antibody targets spondin-1. a secreted extracellular matrix protein encoded by the SPON1 gene. Spondin-1. also known as F-spondin, belongs to the spondin family characterized by thrombospondin type-1 repeat (TSR) domains, which mediate interactions with cell surfaces and extracellular components. It plays roles in neuronal development, including axon guidance, cell adhesion, and neural circuit formation, by modulating signaling pathways such as Wnt and BMP. SPON1 is expressed in the central nervous system, particularly during embryogenesis, and is implicated in tissue repair and regeneration. Dysregulation of SPON1 has been associated with cancers, neurological disorders, and inflammatory conditions.
SPON1 antibodies are widely used in research to study protein expression, localization, and function via techniques like Western blotting, immunohistochemistry, and immunofluorescence. They help elucidate SPON1's involvement in disease mechanisms, such as promoting tumor angiogenesis or suppressing neurodegeneration. Recent studies explore its potential as a biomarker or therapeutic target. However, antibody specificity and cross-reactivity with other spondin family members require careful validation. Overall, SPON1 antibodies serve as critical tools for investigating developmental biology, neural repair, and pathologies linked to extracellular matrix dynamics.